Your browser doesn't support javascript.
loading
Effect of erythropoietin on apoptosis following hyperoxic lung injury in neonatal rats / 中国当代儿科杂志
Chinese Journal of Contemporary Pediatrics ; (12): 576-579, 2010.
Artigo em Chinês | WPRIM | ID: wpr-347540
ABSTRACT
<p><b>OBJECTIVE</b>To study the effect of recombinant human erythropoietin (rhEPO) on apoptosis following hyperoxic lung injury in neonatal rats.</p><p><b>METHODS</b>Ninety-six neonatal Sprague-Dawley rats were randomly divided into four groups air-exposed control, air-exposed rhEPO-treated, hyperoxia-exposed placebo (95% oxygen), and hyperoxia-exposed rhEPO-treated. rhEPO (800 U/kg) was administered 2, 4, and 6 days after air or hyperoxia exposure. The rats were sacrificed 3, 7 and 14 days after air or hyperoxia exposure for the assessment of lung histological changes by hematoxylin and eosin staining (n=8 each time point). p-JNK levels were measured by Western blot. Lung cell apoptosis was evaluated by TUNEL assay.</p><p><b>RESULTS</b>Compared with the air-exposed control group, inflammatory cell infiltration was found at 3 days and increased obviously at 7 days, and widening of the alveolar septa was observed, the number of alveoli decreased and normal alveolarization disappeared at 14 days after hyperoxia exposure in the hyperoxia-exposed placebo group. rhEPO treatment alleviated significantly the hyeroxia-induced alterations in lung pathology. P-JNK protein levels and the number of apoptosis cells decreased significantly in the hyperoxia-exposed rhEPO-treated compared with those in the hyperoxia-exposed placebo group.</p><p><b>CONCLUSIONS</b>rhEPO may reduce apoptosis and thus provide a protective effect against hyperoxic lung injury in neonatal rats. JNK signal pathway may be involved in the protective mechanism.</p>
Assuntos
Texto completo: DisponíveL Índice: WPRIM (Pacífico Ocidental) Assunto principal: Patologia / Farmacologia / Proteínas Recombinantes / Displasia Broncopulmonar / Eritropoetina / Ratos Sprague-Dawley / Apoptose / Hiperóxia / Proteínas Quinases JNK Ativadas por Mitógeno / Tratamento Farmacológico Tipo de estudo: Ensaio Clínico Controlado Limite: Animais / Feminino / Humanos / Masculino Idioma: Chinês Revista: Chinese Journal of Contemporary Pediatrics Ano de publicação: 2010 Tipo de documento: Artigo

Similares

MEDLINE

...
LILACS

LIS

Texto completo: DisponíveL Índice: WPRIM (Pacífico Ocidental) Assunto principal: Patologia / Farmacologia / Proteínas Recombinantes / Displasia Broncopulmonar / Eritropoetina / Ratos Sprague-Dawley / Apoptose / Hiperóxia / Proteínas Quinases JNK Ativadas por Mitógeno / Tratamento Farmacológico Tipo de estudo: Ensaio Clínico Controlado Limite: Animais / Feminino / Humanos / Masculino Idioma: Chinês Revista: Chinese Journal of Contemporary Pediatrics Ano de publicação: 2010 Tipo de documento: Artigo